Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365073
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-10
Brief Title:
A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax
Sponsor:
Qin Ning
Organization:
Tongji Hospital
Study Overview
Official Title:
A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a clinical multi-center retrospective case-control study Patients clinically diagnosed with severe anthrax who meet the inclusion and exclusion criteria will be included in this study for analysis Respiratory circulation nerve and other vital signs of patients with severe anthrax during hospitalization were recorded and clinical data such as blood routine blood biochemistry coagulation function myocardial injury therapeutic drug use and survival time of patients were recorded as well as the survival situation of patients 28 days and 90 days after discharge
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None